iRadimed Corporation (IRMD) earnings
IRMD earnings moved a median of +0.16% by the close. Quarterly and annual IRMD reports and results, each read against the price at its own news timestamp. Back to the IRMD overview →
21 measured IRMD earnings events.
Where these IRMD earnings landedvs 21 measured IRMD earnings reactions
| Middle 50% of IRMD earnings reactions | -1.39% to +2.40% |
|---|---|
| Median reaction (to close) | +0.16% |
| Measured reactions | 21 |
Point-in-time · zero look-ahead
Half of the 21 IRMD earnings events with a measured close landed between -1.39% and +2.40%; 52% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q IRADIMED CORP For: Jun 30 | SEC filing · Form 10-Q | +1.11% | -1.50% | |
| IRADIMED CORPORATION Reports Second Quarter 2026 Financial Results | Press release | +0.00% | -7.04% | |
| IRADIMED CORPORATION to Hold Second Quarter 2026 Financial Results Conference Call on July 31, 2026 | Press release | +0.00% | -0.50% | |
| Form 10-Q IRADIMED CORP For: Mar 31 | SEC filing · Form 10-Q | -2.03% | -1.39% | |
| IRADIMED CORPORATION Reports First Quarter 2026 Financial Results | Press release | -0.16% | +7.38% | |
| IRADIMED CORPORATION to Hold First Quarter 2026 Financial Results Conference Call on May 1, 2026 | Press release | +1.61% | +0.58% | |
| Form 10-K IRADIMED CORP For: Dec 31 | SEC filing · Form 10-K | +0.58% | +2.40% | |
| Form 10-Q IRADIMED CORP For: Sep 30 | SEC filing · Form 10-Q | -4.23% | +3.12% | |
| IRADIMED CORPORATION Reports Record Third Quarter 2025 Financial Results | Press release | -4.45% | +2.26% | |
| Form 10-K/A IRADIMED CORP For: Dec 31 | SEC filing · Form 10-K | — | +1.98% | |
| Form 10-Q IRADIMED CORP For: Jun 30 | SEC filing · Form 10-Q | +0.76% | +5.86% | |
| IRADIMED CORPORATION Reports Record Second Quarter 2025 Financial Results | Press release | -5.30% | +5.42% | |
| Form 10-Q IRADIMED CORP For: Mar 31 | SEC filing · Form 10-Q | +0.00% | -1.35% | |
| IRADIMED CORPORATION Announces First Quarter 2025 Financial Results | Press release | +0.00% | -2.93% | |
| Form 10-K IRADIMED CORP For: Dec 31 | SEC filing · Form 10-K | +0.00% | -0.80% | |
| Form 10-Q IRADIMED CORP For: Sep 30 | SEC filing · Form 10-Q | -0.07% | -1.43% | |
| Form 10-Q IRADIMED CORP For: Jun 30 | SEC filing · Form 10-Q | +0.03% | -0.14% | |
| Form 10-Q IRADIMED CORP For: Mar 31 | SEC filing · Form 10-Q | -0.19% | +0.16% | |
| Form 10-K IRADIMED CORP For: Dec 31 | SEC filing · Form 10-K | +0.00% | +0.38% | |
| Form 10-Q IRADIMED CORP For: Sep 30 | SEC filing · Form 10-Q | +0.00% | -5.44% | |
| IRADIMED CORPORATION Announces Third Quarter 2023 Financial Results | Press release | +3.42% | +3.56% |
Keep exploring
More IRMD: analyst actions → · SEC filings → · IRMD overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Opko Health, Inc. (OPK) | 230 | 0.00% | 51% |
| Veru Inc. (VERU) | 230 | -0.47% | 43% |
| AEVI GENOMIC MEDICINE INC (GNMX) | 227 | 0.00% | 50% |
| AMER BIO MEDICA CORP (ABMC) | 226 | 0.00% | 36% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.